Showing results (21-30 of 25) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Expert Opinion on Investigational Drugs|May 13, 2025
A randomized, double-blind, single dose, parallel group, 2-arm study assessing the pharmacokinetic similarity, pharmacodynamic, safety, tolerability, and immunogenicity profiles of biosimilar candidate AVT03 (60 mg/mL) in healthy male adultsAnel Pretorius, Felicitas Bullo, Lukasz Jaskiewicz, et al.Plos One|July 31, 2015
HIV-1 RNAs are Not Part of the Argonaute 2 Associated RNA Interference Pathway in MacrophagesValentina Vongrad, Jochen Imig, Pejman Mohammadi, et al.Dermatology and Therapy|February 19, 2026
Remibrutinib Showed a Favorable Safety Profile and Sustained Efficacy in Japanese Patients with Chronic Spontaneous Urticaria Over 52 WeeksKoremasa Hayama, Yuko Chinuki, Akiko Yagami, et al.Journal of Clinical Medicine|October 14, 2022
Expression Profiles of AQP3 and AQP4 in Lung Adenocarcinoma Samples Generated via Bronchoscopic BiopsiesLukasz Jaskiewicz, Karolina Hejne, Blazej Szostak, et al.Expert Opinion on Biological Therapy|July 23, 2025
A randomized, double blind, parallel design, repeat dose, 2-arm, multicenter study comparing the efficacy, safety, immunogenicity, and pharmacokinetic profiles of a denosumab biosimilar, AVT03, in postmenopausal women with osteoporosisMamuka Lortkipanidze, Tobie de Villiers, Grzegorz Kania, et al.Pageof 3